Ovid Therapeutics Files 8-K
Ticker: OVID · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Ovid Therapeutics filed an 8-K on 6/25/25 for 'Other Events' - check the details.
AI Summary
Ovid Therapeutics Inc. filed an 8-K on June 25, 2025, reporting an event under "Other Events." The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices located at 441 Ninth Avenue, 14th Floor, New York, NY 10001. The report was filed as of June 25, 2025.
Why It Matters
This filing indicates a material event has occurred for Ovid Therapeutics, requiring public disclosure. Investors should review the details of the 'Other Events' to understand the implications for the company.
Risk Assessment
Risk Level: low — This filing is a standard corporate disclosure and does not inherently indicate significant risk without further context on the 'Other Events'.
Key Numbers
- 001-38085 — SEC File Number (Identifies the company's filing with the SEC.)
- 46-5270895 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Registrant
- June 25, 2025 (date) — Date of Report
- 441 Ninth Avenue, 14th Floor, New York, New York 10001 (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
What specific event is being reported under 'Other Events' in this 8-K filing?
The provided text does not specify the exact nature of the 'Other Events'; it only indicates that this section is being reported.
When was the earliest event reported in this filing?
The date of the earliest event reported is June 25, 2025.
What is Ovid Therapeutics Inc.'s principal executive office address?
The principal executive offices are located at 441 Ninth Avenue, 14th Floor, New York, New York 10001.
In which state was Ovid Therapeutics Inc. incorporated?
Ovid Therapeutics Inc. was incorporated in Delaware.
What is the SEC file number for Ovid Therapeutics Inc.?
The SEC file number for Ovid Therapeutics Inc. is 001-38085.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Ovid Therapeutics Inc. (OVID).